Jadpro: Managing Classical Hodgkin Lymphoma With Antibodydrug Conjugates

Amy Goodrich, RN, MSN, CRNP-AC, and Barbara Rogers, CRNP, MN, AOCN®, ANP-BC, review best practices for anticipating and managing side effects for patients being treated for classical Hodgkin lymphoma, including the short- and long-term adverse events associated with chemotherapy, checkpoint inhibitors, and antibody–drug conjugates.Instructions for CE credit:If you would like to earn credit, you must take the pre-test first by visiting https://education.annenberg.net/5701-EM2To finish earning credit, you must take the post-test by visiting https://education.annenberg.net/node/9812/take/1